ARTICLE | Company News
ImmuneRegen, Azopharma Product Development Group deal
September 28, 2009 7:00 AM UTC
The companies signed a letter of intent for CRO Azopharma to perform manufacturing, formulation development, preclinical toxicology and pharmacology studies of ImmuneRegen's Homspera. The analog of t...